Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Vávrová, , Ludmila,
DOB: 08-AUG-1940 (Age: 85)
Gender: female
Address:
Šárovo Kolo 116
29471 Bakov nad Jizerou (Czechia)
ID: 1992-540676-1 (ECI)
Report
Date: 04-NOV-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Psychiatrická nemocnice Kosmonosy
293 06 Kosmonosy (Czechia)
Specimen
Collected: 04-NOV-2020

Chemistry

Test 04-NOV-2020 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 253.2 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 142.7 10 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 174.2 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.5 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated total cholesterol and LDL cholesterol levels, while triglycerides and HDL cholesterol are within normal limits. These findings indicate increased cardiovascular risk and may warrant further clinical evaluation and consideration of lipid-lowering therapy, especially given the patient's advanced age.